0.5568
Precedente Chiudi:
$0.5696
Aprire:
$0.57
Volume 24 ore:
972.88K
Relative Volume:
1.31
Capitalizzazione di mercato:
$48.10M
Reddito:
$2.24M
Utile/perdita netta:
$-136.67M
Rapporto P/E:
-0.2431
EPS:
-2.29
Flusso di cassa netto:
$-102.08M
1 W Prestazione:
-6.73%
1M Prestazione:
+13.68%
6M Prestazione:
+11.36%
1 anno Prestazione:
-64.54%
Century Therapeutics Inc Stock (IPSC) Company Profile
Nome
Century Therapeutics Inc
Settore
Industria
Telefono
215-981-4000
Indirizzo
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Confronta IPSC con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
IPSC
Century Therapeutics Inc
|
0.5568 | 48.35M | 2.24M | -136.67M | -102.08M | -2.29 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-08-08 | Iniziato | Rodman & Renshaw | Buy |
2023-08-28 | Downgrade | JP Morgan | Overweight → Neutral |
2022-12-27 | Iniziato | Chardan Capital Markets | Buy |
2022-10-31 | Iniziato | Guggenheim | Buy |
2022-10-10 | Iniziato | Canaccord Genuity | Buy |
2022-05-23 | Iniziato | H.C. Wainwright | Buy |
2022-05-12 | Iniziato | William Blair | Mkt Perform |
2021-07-13 | Iniziato | BofA Securities | Buy |
2021-07-13 | Iniziato | JP Morgan | Overweight |
2021-07-13 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Century Therapeutics Inc Borsa (IPSC) Ultime notizie
How to manage a losing position in Century Therapeutics Inc.Share Buyback & Consistent Income Trade Recommendations - newser.com
Century Therapeutics Inc. stock momentum explainedRisk Management & Consistent Income Trade Recommendations - newser.com
Is Century Therapeutics Inc. stock reversal real or fakeProduct Launch & Verified Momentum Stock Alerts - newser.com
Can Century Therapeutics Inc. recover in the next quarterMarket Activity Summary & Consistent Income Trade Recommendations - newser.com
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference - GlobeNewswire
Century Therapeutics Inc. stock volume spike explainedTrade Analysis Report & Fast Momentum Entry Tips - newser.com
Is Century Therapeutics Inc. stock positioned well for digital economyPortfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com
How Century Therapeutics Inc. stock trades before earningsWeekly Loss Report & Community Driven Trade Alerts - newser.com
Will Century Therapeutics Inc. rebound enough to break evenJuly 2025 Final Week & Proven Capital Preservation Tips - newser.com
Is Century Therapeutics Inc. building a consolidation baseQuarterly Trade Report & Precise Trade Entry Recommendations - newser.com
Is now a turning point for Century Therapeutics Inc.July 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com
Applying chart zones and confluence areas to Century Therapeutics Inc.2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com
How to use a screener to detect Century Therapeutics Inc. breakoutsMarket Trend Review & Reliable Volume Spike Alerts - newser.com
We Think Century Therapeutics (NASDAQ:IPSC) Needs To Drive Business Growth Carefully - Yahoo Finance
Century Therapeutics (NASDAQ:IPSC) Upgraded by Wall Street Zen to Hold Rating - Defense World
Century Therapeutics Inc. stock outlook for YEARMarket Volume Report & Fast Exit/Entry Strategy Plans - newser.com
Does Century Therapeutics Inc. fit your quant trading modelJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
What the charts say about Century Therapeutics Inc. today2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com
Critical Analysis: Century Therapeutics (NASDAQ:IPSC) and TransCode Therapeutics (NASDAQ:RNAZ) - Defense World
Layoff Tracker: Novo’s Cuts Leave Dozens of Manufacturing Workers Jobless - BioSpace
There Is A Reason Century Therapeutics, Inc.'s (NASDAQ:IPSC) Price Is Undemanding - simplywall.st
How to escape a deep drawdown in Century Therapeutics Inc.July 2025 Update & Verified Momentum Stock Watchlist - newser.com
Analysts Set Century Therapeutics, Inc. (NASDAQ:IPSC) Price Target at $3.75 - Defense World
Century Therapeutics Inc. recovery potential after sell offMarket Activity Recap & Risk Controlled Stock Pick Alerts - newser.com
How to build a dashboard for Century Therapeutics Inc. stockJobs Report & Community Consensus Trade Signals - newser.com
Is Century Therapeutics Inc. stock ready for a breakoutMarket Risk Analysis & Fast Moving Trade Plans - newser.com
Why Century Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Century Therapeutics Inc Azioni (IPSC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Century Therapeutics Inc Azioni (IPSC) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Pfeiffenberger Brent | President and CEO |
Sep 08 '25 |
Sale |
0.50 |
488 |
244 |
3,268,909 |
Russotti Gregory | See Remarks |
Sep 08 '25 |
Sale |
0.50 |
539 |
270 |
391,508 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):